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Background: Risk adjustment is important in studies using administrative databases. Although utilization of
diagnostic and therapeutic procedures can represent patient severity, the usability of procedure records in risk
adjustment is not well-documented. Therefore, we aimed to develop and validate a severity index calculable from
procedure records.
Methods: Using the Japanese nationwide Diagnosis Procedure Combination database of acute-care hospitals, we
identified patients discharged between 1 April 2012 and 31 March 2013 with an admission-precipitating diagnosis
of acute myocardial infarction, congestive heart failure, acute cerebrovascular disease, gastrointestinal hemorrhage,
pneumonia, or septicemia. Subjects were randomly assigned to the derivation cohort or the validation cohort. In
the derivation cohort, we used multivariable logistic regression analysis to identify procedures performed on
admission day which were significantly associated with in-hospital death, and a point corresponding to regression
coefficient was assigned to each procedure. An index was then calculated in the validation cohort as sum of points for
performed procedures, and performance of mortality-predicting model using the index and other patient characteristics
was evaluated.
Results: Of the 539 385 hospitalizations included, 270 054 and 269 331 were assigned to the derivation and validation
cohorts, respectively. Nineteen significant procedures were identified from the derivation cohort with points ranging
from −3 to 23, producing a severity index with possible range of −13 to 69. In the validation cohort, c-statistic of
mortality-predicting model was 0.767 (95 % confidence interval: 0.764–0.770). The ω-statistic representing contribution
of the index relative to other variables was 1.09 (95 % confidence interval: 1.03–1.17).
Conclusions: Procedure-based severity index predicted mortality well, suggesting that procedure records in
administrative database are useful for risk adjustment.
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Risk adjustment is an important component in clinical
epidemiology and health services research using adminis-
trative databases, but its methods remain controversial.
Administrative databases are widely used in studies be-
cause of their availability and large sample sizes, and risk-
adjusted mortality is employed as one of the outcome
measures. However, the validity of risk-adjustment models* Correspondence: yasunagah-tky@umin.ac.jp
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[1–4]. It has been argued that administrative data lack
important clinical information [5–8] and often do not
make distinctions between conditions present on admis-
sion and complications occurring during hospitalization
[6–10]. Inadequate risk adjustment can lead to misleading
consequences such as confounding by indications and low
rating of facilities that care for sicker patients. Thus,
appropriate risk-adjustment models are desired.
Previous studies have shown that the performance of
risk-adjustment models using administrative databases
improves when detailed clinical information is added. Inarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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bid illnesses recorded in administrative data enabled risk
adjustment using measures such as the Charlson comor-
bidity index (CCI) [11]. Furthermore, models using labora-
tory data, vital signs, and other clinical findings provided
better predictions of mortality [12–15], and models
using disease-specific diagnostic tests and treatments
have been introduced for some diseases [16–19]. Mean-
while, precise laboratory and clinical data are not avail-
able in most administrative databases. Therefore, an
alternative method has been reported, in which surger-
ies and major therapeutic procedures are associated
with in-hospital death [20].
In addition to major therapeutic procedures, commonly
performed procedures, diagnostic or therapeutic, can
reflect the severity of patients on admission. For ex-
ample, patients who receive oxygen therapy are ex-
pected to be in a severe condition compared with
those who do not. However, there have been no evalu-
ations of risk-adjustment models that use commonly
performed procedures. In addition, previous models
using laboratory and clinical data were developed and
validated in limited regions.
The aims of the present study were to develop an
index of severity using procedure records in a nation-
wide database, and to examine the ability of this index
to predict in-hospital death.
Methods
Data source
The Diagnosis Procedure Combination database is a
national administrative database of acute-care inpa-
tients in Japan that is linked with a payment system.
The mandatory-participating academic hospitals (all 82
hospitals) and voluntary-participating community hospitals
provide claims data of all of their acute-care inpatients. In
2012, there were approximately 1,000 participating hospi-
tals with 7 million admissions recorded annually, repre-
senting 50 % of all acute-care hospitalizations in Japan.
The database includes the following data: hospital
identification code; patient demographics; diagnoses; ad-
mission and discharge status; surgeries and procedures
performed; drugs used; and special reimbursements for
specific conditions. Up to 12 diagnoses for each admis-
sion are recorded, and coded using the International
Classification of Diseases, Tenth Revision (ICD-10). One
diagnosis each is recorded for “main diagnosis,” “admis-
sion-precipitating diagnosis,” “most resource-consuming
diagnosis,” and “second most resource-consuming diag-
nosis.” A maximum of four diagnoses each are recorded
for “comorbidities present on admission” and “condi-
tions arising after admission.” Suspected diagnoses are
allowed to be recorded, in which case they are desig-
nated as such. Surgeries, drugs, procedures, and specialreimbursements are coded according to the Japanese fee
schedule for reimbursement [21], and their dates of use
or application are recorded. The daily quantities of each
drug administered are also recorded.
Study cohort
We included all adult patients (≥18 years) discharged be-
tween 1 April 2012 and 31 March 2013 with a confirmed
admission-precipitating diagnosis of acute myocardial
infarction, congestive heart failure, acute cerebrovascular
disease, gastrointestinal hemorrhage, pneumonia, or septi-
cemia. The identification of these six diseases was based
on the Classifications Software for Mortality Reporting de-
veloped by the Healthcare Cost and Utilization Project
[22], and the following Classifications Software categories
were used for the six diseases, respectively: 100, 108, 109,
153, 122, and 2. For congestive heart failure, we also
included hypertensive heart disease with heart failure
(ICD-10 code: I11.0, I13.0, or I13.2). We excluded the
following patients based on their information on the day of
admission: those who were admitted to intensive care unit
(including coronary care unit); and those who received
cardiopulmonary life support (cardiopulmonary resusci-
tation, electrical cardioversion, cardiopulmonary bypass,
extracorporeal membrane oxygenation, or ventricular as-
sist device). We identified the former using reimbursement
information, and the latter using procedure information.
The data for diagnostic and therapeutic procedures
performed on the day of admission, use of catechol-
amines (epinephrine, norepinephrine, dopamine, and do-
butamine) and vasopressin on the day of admission, and
use of blood transfusions (red blood cells, platelets, fresh
frozen plasma, and albumin) on the day of admission
were extracted. A list of the procedures and codes exam-
ined in this study is shown in the Additional file 1. For
the examinations, examples of the tested items are also
listed. Patients who underwent at least one procedure
categorized under a given code were assigned that spe-
cific code. For example, “D007, blood chemistry tests”
would be coded for patients who underwent creatinine
testing, as well as for patients who underwent sodium,
potassium, and chloride testing. Comorbidities were ex-
amined using the diagnoses recorded as comorbidities
present on admission, and CCI values were calculated
using the coding algorithm [23] and weight assignment
[24] reported by Quan et al.
We randomly assigned the eligible patients to the der-
ivation cohort or validation cohort. We developed the
severity index for inpatients using the derivation cohort,
and tested its performance in the validation cohort.
Index development
In the derivation cohort, we first examined the proportion
of patients who underwent each procedure (including use
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mission. For each procedure with ≥1 % prevalence, the
chi-square test was used to evaluate the association
with in-hospital death. The procedures positively asso-
ciated with in-hospital death (P < 0.1) were retained for
further analysis. Procedures with a correlation (phi co-
efficient >0.6) were managed in the following manner:
(i) a group of procedures usually performed simultan-
eously were combined into a single variable as at least one
procedure; and (ii) for a group of procedures performed
consecutively, only the procedure usually performed first
was retained. Subsequently, a logistic regression model
was developed with in-hospital death as the outcome vari-
able. In the model, the admission-precipitating diagnosis,
age, sex, and CCI were included as categorical covariates
(age categories: <60, 60–69, 70–79, 80–89, ≥90; CCI
categories: 0, 1, 2, ≥3) in addition to the procedures.
Using the statistically significant (P < 0.05) regression
coefficients obtained with the model, we derived an
index-calculating formula by the method of Sullivan
et al. [25], using CCI = 1 as a reference. Specifically, a
point was assigned to each procedure so that it equaled
the integer nearest to the quotient of the regression coeffi-
cient for the procedure divided by the regression coeffi-
cient for CCI = 1. Thus, the points for each procedure
were derived to represent the effect on death relative to
the CCI. The severity index for each patient could then be
calculated as the sum of the points assigned to the proce-
dures performed on the patient.
Index validation
The severity index was calculated for patients in the valid-
ation cohort. We examined the distribution of its values,
and used a logistic regression model with the index as a
continuous variable (model 1) to examine its association
with in-hospital death. For every value, the expected death
rate among patients with the value was compared with the
observed death rate.
We then constructed multiple logistic regression models
with different independent variables: severity index, diag-
nosis, age, and sex (model 2); diagnosis, age, sex, and CCI
(model 3); severity index, diagnosis, age, sex, and CCI
(model 4). The discriminatory abilities of the different
models were assessed using the c-statistics. We used
the integrated discrimination improvement (IDI) [26]
to evaluate the improvement of model discrimination
by adding the severity index. The IDI is a difference in
the discrimination slope (difference between the mean
predicted probability of an event for those with events
and the corresponding mean predicted probability of
an event for those without events) between two models
and is a measure of the improvement in model perform-
ance. In this study, the IDI was calculated for a compari-
son of model 4 with model 3.We evaluated the relative contribution of the severity
index to the prediction of death using the ω-statistic
[27]. The ω-statistic is the ratio of the variances of the
contributions of two groups of variables to the log-odds
of the outcome in a logistic regression model. In this
study, we used model 4, and compared the relative con-
tribution of the severity index with that of four other
variables. In addition, the calibration of model 4 was
evaluated using the Hosmer–Lemeshow decile partition.
We conducted further analyses to test the perform-
ance of the severity index across various subgroups of
patients. Using the severity index derived from all pa-
tients in the derivation cohort, model 4 was constructed
for the following subgroups of the validation cohort:
those who arrived in an ambulance and those who did
not; those who were referred by another institution and
those with no referral. We also built models for each
admission-precipitating diagnosis, with severity index,
age, sex, and CCI as independent variables. The model
discrimination and calibration were evaluated for each
subgroup.
The P values were 2 sided. Statistical analyses were per-
formed using IBM SPSS for Windows, version 22.0 (IBM
Corp., Armonk, NY, USA). Because of the anonymous
nature of the data, the need for informed consent was
waived. Study approval was obtained from the Institu-
tional Review Board of The University of Tokyo.
Results
Patient characteristics
We identified 604,579 adult patients with one of the six
diseases as the admission-precipitating diagnosis during
the study period. Of these patients, 65,194 were excluded
because of intensive care unit admission (n = 59,995) or
cardiopulmonary life support (n = 7,019) on the day of
admission, leaving 539,385 patients for analysis. For
these patients, the mean age was 74.1 years, 57.5 %
were male, and the in-hospital mortality rate was 9.5 %.
The background characteristics of all patients, patients
assigned to the derivation cohort (n = 270,054), and pa-
tients assigned to the validation cohort (n = 269,331)
are presented in Table 1. The characteristics were simi-
lar between the two cohorts.
Index development
There were 38 procedures with ≥1 % prevalence in the
derivation cohort. Their rate of use in the surviving and
deceased patients, and the results of chi-square tests are
presented in Table 2. Of the 28 procedures significantly
associated with in-hospital death, 11 were correlated
with each other in five groups. The three blood examina-
tions (blood chemistry, hematology, plasma protein im-
munology), two urine examinations (general urine test,
urine microscopy), and two microbiological examinations
Table 1 Characteristics of patients included in the study
Derivation cohort Validation cohort All patients
Total number 270 054 269 331 539 385
Admission-precipitating diagnosis, n (%)
Acute myocardial infarction 10 421 (3.9) 10 176 (3.8) 20 597 (3.8)
Congestive heart failure 56 970 (21.1) 56 927 (21.1) 113 897 (21.1)
Acute cerebrovascular disease 89 983 (33.3) 90 071 (33.4) 180 054 (33.4)
Gastrointestinal hemorrhage 35 073 (13.0) 34 429 (12.8) 69 502 (12.9)
Pneumonia 68 387 (25.3) 68 386 (25.4) 136 773 (25.4)
Septicemia 9220 (3.4) 9342 (3.5) 18 562 (3.4)
Male, n (%) 155 273 (57.5) 154 857 (57.5) 310 130 (57.5)
Age, mean (SD) 74.1 (14.2) 74.1 (14.2) 74.1 (14.2)
Age by category, n (%)
<60 37 363 (13.8) 37 425 (13.9) 74 788 (13.9)
60–69 47 235 (17.5) 46 833 (17.4) 94 068 (17.4)
70–79 73 468 (27.2) 73 509 (27.3) 146 977 (27.2)
80–89 84 965 (31.5) 84 964 (31.5) 169 929 (31.5)
≥90 27 023 (10.0) 26 600 (9.9) 53 623 (9.9)
Charlson comorbidity index, n (%)
0 162 038 (60.0) 161 597 (60.0) 323 635 (60.0)
1 34 307 (12.7) 34 015 (12.6) 68 322 (12.7)
2 52 841 (19.6) 52 688 (19.6) 105 529 (19.6)
≥3 20 868 (7.7) 21 031 (7.8) 41 899 (7.8)
In-hospital death, n (%) 25 638 (9.5) 25 449 (9.4) 51 087 (9.5)
Length of stay in days, median (IQR) 15 (9–29) 15 (9–29) 15 (9–29)
IQR – interquartile range
SD – standard deviation
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as blood tests (excluding coagulation), urinalyses (ex-
cluding chemistry), and bacterial microscopy or culture,
respectively. Thus, for example, “blood tests (excluding
coagulation)” would be counted for patients who under-
went sodium, potassium, and hemoglobin testing, as well
as for patients who underwent C-reactive protein testing.
Central venous infusion and oxygen administration
were respectively correlated with central venous catheter
insertion and pulse oximetry, which logically precede each
procedure. Therefore, central venous catheter insertion
and pulse oximetry were retained, while central venous in-
fusion and oxygen administration were excluded from the
analysis. The 22 candidate variables were then entered
into a logistic regression model, the results of which are
presented in Table 3. There were seven procedure vari-
ables significantly associated with decreased risk of death,
and twelve procedure variables significantly associated
with increased risk of death. Because CCI = 1 was not
significantly associated with increased odds of death,
we divided the regression coefficient for CCI = 2 (0.182)by two to obtain an estimate for the coefficient for CCI = 1
and used it as a reference. The points assigned to each
procedure are also presented in Table 3.
Index performance
The severity index calculated for patients in the validation
cohort ranged from −12 to 62, with a mean of 2.13 (stand-
ard deviation: 6.85). The distribution of the index values in
the validation cohort is presented in Fig. 1. The values
with small numbers of patients were grouped to include at
least 1 % of the patients. The observed death rates for the
values and their 95 % confidence intervals (CI) and the ex-
pected death rates are also presented.
The c-statistics for models 1, 2, 3, and 4 were 0.701
(95 % CI: 0.698, 0.705), 0.758 (95 % CI: 0.755, 0.761),
0.675 (95 % CI: 0.672, 0.679), and 0.767 (95 % CI: 0.764,
0.770), respectively. The IDI for the comparison of
model 4 with model 3 was 0.0700 (95 % CI: 0.0682,
0.0719), representing improved discrimination in model
4. The ω-statistic in model 4 was 1.09 (95 % CI: 1.03,
1.17), representing a slightly larger contribution of the
Table 2 Procedures with ≥1 % prevalence in the derivation cohort
Surviving patients (n = 244 416) Deceased patients (n = 25 638) P valuea
% (n) % (n)
Blood chemistry tests 87.2 (213 046) 89.5 (22 949) <0.001
Hematology tests 86.1 (210 402) 88.6 (22 704) <0.001
Plasma protein immunology testsb 81.0 (198 064) 85.4 (21 896) <0.001
Radiography 78.1 (190 981) 81.6 (20 922) <0.001
Electrocardiogram 69.3 (169 490) 69.7 (17 869) 0.244 #
Peripheral intravenous infusion 65.1 (159 043) 72.5 (18 581) <0.001
Coagulation tests 59.5 (145 418) 62.2 (15 937) <0.001
Computed tomography scan 50.6 (123 559) 62.2 (15 938) <0.001
Infectious disease immunology testsc 50.5 (123 481) 49.2 (12 622) <0.001 †
Hepatitis virus tests 39.5 (96 552) 37.8 (9681) <0.001 †
Heart rate/respiration monitoring 37.4 (91 457) 49.8 (12 770) <0.001
Pulse oximetry 34.9 (85 254) 51.2 (13 128) <0.001
Oxygen administration 30.5 (74 526) 54.5 (13 961) <0.001
Urine tests (general) 32.0 (78 225) 35.3 (9046) <0.001
Endocrinology tests 28.3 (69 282) 32.1 (8222) <0.001
Bacterial culture 25.0 (61 069) 34.5 (8852) <0.001
Urine microscopy 21.6 (52 891) 24.2 (6211) <0.001
Immunohematology testsd 21.8 (53 197) 21.4 (5486) 0.175 #
Bacterial microscopy 20.1 (49 180) 27.8 (7127) <0.001
Urinary catheter insertion 18.0 (43 933) 37.2 (9534) <0.001
Ultrasound imaging 18.9 (46 118) 18.8 (4830) 0.909 #
Magnetic resonance imaging 18.6 (45 489) 10.2 (2615) <0.001 †
Acid-fast bacilli culture 8.5 (20 879) 10.6 (2727) <0.001
Bacterial drug susceptibility tests 7.2 (17 667) 12.7 (3267) <0.001
Sputum suction 5.3 (13 061) 22.2 (5680) <0.001
Use of catecholamines or vasopressin 5.1 (12 371) 12.3 (3143) <0.001
Red blood cell transfusion 5.0 (12 268) 5.2 (1324) 0.313 #
Nucleic acid amplification tests 3.7 (9102) 4.6 (1178) <0.001
Tumor markers 3.3 (8018) 2.6 (667) <0.001 †
Invasive arterial pressure measurement 2.3 (5649) 4.4 (1130) <0.001
Autoantibody tests 2.3 (5740) 1.9 (488) <0.001 †
Urine chemistry tests 2.1 (5130) 2.6 (654) <0.001
Gastric drainage tube insertion 1.6 (3993) 6.1 (1559) <0.001
Central venous catheter insertion 1.2 (2997) 5.3 (1346) <0.001
Intratracheal intubation 0.9 (2252) 7.7 (1963) <0.001
Stool tests 1.4 (3377) 1.2 (311) 0.027 †
Central venous infusion 1.0 (2467) 4.5 (1163) <0.001
Temporary urinary catheterization 1.0 (2465) 1.4 (352) <0.001
aThe P values were obtained by the chi-square test for in-hospital death
bFor example, C-reactive protein, complement activity
cFor example, viral antibody tests, β-D-glucan assay
dFor example, blood type test, Coombs test
# Not significant
† Significantly associated with decreased risk of death
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Table 3 Result of logistic regression analysis in the derivation cohort and points assigned to each procedure
Variable β exp(β) 95 % CI P value Points for procedure
Admission-precipitating diagnosis
Acute myocardial infarction Ref
Congestive heart failure −0.10 0.90 0.83 – 0.98 0.012
Acute cerebrovascular disease −0.11 0.90 0.82 – 0.97 0.010
Gastrointestinal hemorrhage −0.51 0.60 0.55 – 0.66 <0.001
Pneumonia 0.04 1.04 0.95 – 1.13 0.405
Septicemia 0.73 2.07 1.87 – 2.28 <0.001
Sex (female) −0.12 0.89 0.86 – 0.91 <0.001
Age
<60 Ref
60–69 0.35 1.43 1.33 – 1.53 <0.001
70–79 0.68 1.98 1.86 – 2.11 <0.001
80–89 1.14 3.12 2.94 – 3.31 <0.001
≥90 1.60 4.96 4.65 – 5.30 <0.001
Charlson comorbidity index
0 Ref
1 0.03 1.03 0.98 – 1.07 0.233
2 0.18 1.20 1.16 – 1.24 <0.001
≥3 0.72 2.05 1.96 – 2.14 <0.001
Procedure
Invasive arterial pressure measurement −0.30 0.74 0.68 – 0.81 <0.001 −3
Blood tests (excluding coagulation) −0.26 0.77 0.73 – 0.81 <0.001 −3
Radiography −0.20 0.82 0.79 – 0.86 <0.001 −2
Urinalyses (excluding chemistry) −0.18 0.84 0.81 – 0.87 <0.001 −2
Temporary urinary catheterization −0.18 0.84 0.74 – 0.94 0.004 −1
Endocrinology tests −0.06 0.94 0.91 – 0.97 <0.001 −1
Bacterial microscopy or culture −0.05 0.95 0.91 – 0.99 0.019 −1
Acid-fast bacilli culture −0.04 0.96 0.91 – 1.02 0.206 #
Coagulation tests −0.03 0.97 0.94 – 1.01 0.117 #
Nucleic acid amplification tests 0.01 1.01 0.93 – 1.09 0.842 #
Bacterial drug susceptibility tests 0.06 1.06 1.01 – 1.12 0.022 1
Urine chemistry tests 0.10 1.10 1.00 – 1.21 0.041 1
Heart rate/respiration monitoring 0.18 1.20 1.16 – 1.24 <0.001 2
Peripheral intravenous infusion 0.18 1.20 1.16 – 1.24 <0.001 2
Computed tomography scan 0.25 1.28 1.24 – 1.32 <0.001 3
Pulse oximetry 0.29 1.33 1.29 – 1.37 <0.001 3
Gastric drainage tube insertion 0.32 1.38 1.27 – 1.50 <0.001 4
Urinary catheter insertion 0.47 1.60 1.55 – 1.66 <0.001 5
Central venous catheter insertion 0.49 1.63 1.49 – 1.77 <0.001 5
Use of catecholamines or vasopressin 0.70 2.02 1.92 – 2.13 <0.001 8
Sputum suction 1.11 3.04 2.92 – 3.16 <0.001 12
Intratracheal intubation 2.05 7.77 7.14 – 8.45 <0.001 23
# No points assigned because of non-significance of the coefficient
CI – confidence interval








































Fig. 1 Distribution of the severity index and observed and expected death rates in the validation cohort. The box plots indicate the observed
mortality rates and their 95 % confidence intervals
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Model 4 was well-calibrated, as shown by the Hosmer–
Lemeshow calibration plot presented in Fig. 2.
The mortality rates and c-statistics of the subgroups of
patients are presented in Table 4. The model was well-
calibrated for each diagnosis, as shown in Fig. 3. The
























Fig. 2 Calibration plot of the model predicting in-hospital death in
the validation cohortDiscussion
Using the Diagnosis Procedure Combination nationwide
administrative database of acute-care hospitals, we derived
and internally validated a severity index for inpatients that
utilizes procedure records to predict in-hospital death. In
the patients with the six diseases examined, the index was
widely distributed, and the model combining the severity
index with age, sex, and CCI predicted in-hospital death
well (c-statistic: 0.767).
We used procedures performed on the day of admission
as indicators of severity on admission, and extracted 19
commonly performed procedures, diagnostic and thera-
peutic, that were significantly associated with in-hospital
death or survival. The characteristics of the procedures
differed widely, from routinely performed procedures (e.g.
blood examinations) to those reflecting critically ill condi-
tions (e.g. intratracheal intubation). This difference was
represented in the weights given to each procedure, ran-
ging from −3 to 23. The weights represented the strength
of association between each procedure and death, relative
to an increase in the CCI. The weighted numbers of the
performed procedures were then summed into an index
with a possible range of −13 to 69.
The mortality-predicting model with only diagnosis, age,
sex, and CCI (model 3) had a fair discriminating ability
(c-statistic: 0.675), and there was a significant improve-
ment on the model performance when the severity
index was added (IDI: 0.0700; c-statistic of model 4:
0.767). Furthermore, in model 4, the index contributed to
the prediction of death more than all the other variables
Table 4 Results of subgroup analyses
n Mortality rate c-statistic 95 % CI
Admission-precipitating diagnosis
Acute myocardial infarction 10 176 8.6 % 0.821 0.806 – 0.836
Congestive heart failure 56 927 9.8 % 0.709 0.702 – 0.716
Acute cerebrovascular disease 90 071 8.6 % 0.801 0.796 – 0.807
Gastrointestinal hemorrhage 34 429 4.7 % 0.791 0.780 – 0.801
Pneumonia 68 386 11.0 % 0.733 0.727 – 0.739
Septicemia 9342 22.4 % 0.699 0.686 – 0.711
Admission by ambulance
No 166 979 6.5 % 0.769 0.764 – 0.773
Yes 102 327 14.3 % 0.744 0.740 – 0.748
Referral from another institution
No 161 494 9.9 % 0.769 0.766 – 0.773
Yes 107 808 8.8 % 0.762 0.757 – 0.767
Hospital type
Non-academic 225 479 9.6 % 0.767 0.764 – 0.770
Academic 34 162 8.3 % 0.759 0.749 – 0.769
CI – confidence interval
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importance of the severity index for predicting mortality.
To our knowledge, this is the first study to examine a
mortality prediction model with commonly used pro-
cedures and medications, and the results suggest the
usability of procedure records for risk adjustment.
Similar to other studies [12, 13], we chose six high-
impact medical conditions (acute myocardial infarction,
congestive heart failure, acute cerebrovascular disease,
gastrointestinal hemorrhage, pneumonia, septicemia) as
the target diseases. Although the single model had a
good discriminating ability and was well-calibrated
across various subgroups, the c-statistics ranged from 0.70
for septicemia to 0.82 for acute myocardial infarction. A
previous study that used demographics, admission diagno-
sis, comorbidity-based score, and laboratory-based score
as variables had similar results, in which the c-statistics
were ≥0.80 for 29 admission diagnoses, 0.71–0.80 for
13 admission diagnoses, and <0.70 for two admission
diagnoses [14]. Use of the same model for various primary
illnesses may result in variable predictive ability across
diagnoses because the effects of procedures on mortality
may differ across diagnoses. In addition, the main diagno-
sis or main therapeutic procedure themselves are predic-
tors of mortality [14, 15, 20]. Therefore, care should be
taken when comparing these results with models derived
separately for different diagnoses, which often yield higher
c-statistics [12, 13, 16–19].
Although comorbidities recorded in administrative da-
tabases have provided fairly good predictions of mortal-
ity, there have been concerns that diagnoses may reflectcomplications instead of comorbidities [6–10]. The use
of numerical laboratory data is one method suggested by
researchers, and high model c-statistics of >0.8 were ob-
served [12–16]. When available, laboratory data provide
precise information about patient severity on admission
and help to improve the model performance. However,
implementation of an administrative database with labora-
tory data requires considerable cost and effort, and previ-
ous studies were thus confined to regional databases. In
contrast, our study was conducted using a preexisting na-
tionwide administrative database, and the procedures
added considerable predictive ability to a model using
demographics and comorbidities. The method presented
here could be useful for similar databases with procedure
data. For databases without procedure data, we recom-
mend adding such data because it is relatively inexpensive
and useful for mortality prediction.
Our study has several strengths. First, it was conducted
using a nationwide database, and included patients of all
ages treated in hospitals with different characteristics in all
areas of Japan. Second, chronological information was
considered in the diagnoses and procedures. We used the
“admission-precipitating diagnosis” for case identification
and the “comorbidities present on admission” for comor-
bidities. Similar to the use of “present on admission” codes
in the previous US studies [12, 28] and “diagnosis-type in-
dicator” codes in the previous Canadian studies [9, 29],
our method prevents the misclassification of complica-
tions occurring during hospitalization as main diagnoses
or comorbidities. Likewise, the information regarding














































































































































Fig. 3 Calibration plots of models predicting in-hospital death in the validation cohort for six admissionprecipitating diagnoses (a, acute
myocardial infarction; b, congestive heart failure; c, acute cerebrovascular disease; d, gastrointestinal hemorrhage; e, pneumonia; f, septicemia)
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we used the aspects of whether or not the procedures
were performed as variables. Although procedure data are
not as objective as automatically-recorded laboratory data,
we believe that the validity of procedure data is higher
than that of recorded diagnoses.
This study has several limitations. First, we only exam-
ined six medical conditions. It is unknown whether the
severity index for inpatients developed in the present
study is applicable to patients hospitalized for other con-
ditions. Second, we excluded patients with critically ill
conditions on the day of admission, because we expected
that the associations of procedures with mortality would
be different in these patients. Although some severe pa-
tients, such as intubated patients and those on catechol-
amines, were treated in general wards, as sometimes
occurs in Japan [30, 31], and were thus included in the
analysis, the issue of whether the index is valid for most
critically ill patients, e.g. those admitted to the intensive
care unit, requires further examination. Third, we lim-
ited the drugs to catecholamines and vasopressin, but
other treatments such as intravenous fluids and antibi-
otics could also represent the severity on admission.
Fourth, each admission was considered independent in
the analyses. Better mortality prediction may be possible
when clustering within patient and within site is taken
into account. Also, the variance within each procedure,
e.g., numbers or types of tested items within a blood
test, was not accounted for. Last, the study was con-
ducted in Japan using procedure codes in the Japanese
fee reimbursement system, and the use of this index in
other countries with different routine practices and cod-
ing systems will require appropriate conversions.Conclusion
The newly developed severity index for inpatients using
procedure records predicted in-hospital death well. Fur-
ther validating research should lead to its application to
risk adjustment.Additional file
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